Oncology Information System Market

Oncology Information System Market by Software (Patient Information System, TPS, RIS, PACS, Services), Application (Medical, Radiation, Surgical Oncology), Enduser (Hospitals, Cancer Care Centers, Government Institution, Academia) - Global Forecast to 2025

Report Code: HIT 3267 Feb, 2021, by marketsandmarkets.com

[266 Pages Report] The oncology information systems market is projected to reach USD 9.5 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 7.4% during the forecast period. Usage of blockchain technology in oncology information systems is a key trend for a medical ecosystem in cancer care, resulting in the elimination for the paper based records and treatment plans thus, it is the key factors supporting the growth of the market.

Oncology Information System Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global Oncology information systems market

As a result of the pandemic, during March 2020 and throughout the second quarter of 2020, access to customers to sell and implement the oncology information systems diminished as hospitals became primarily focused on the COVID-19 pandemic. The pandemic has led to a significant decreae in the demand for  oncology information solutions. The pandemic has also affected the oncology field since doctors are not adequately able to concentrate on regular patients since they are being redeployed for treating COVID-19 patients. Therefore, performing oncology surgery and therapy has become a significant challenge with the non-availability of hospital staff and operation facilities. Furthermore, the market for oncology information systems  is expecting to recover the losses by the fourth quarter of 2020.

Oncology Information Systems Market Dynamics

Driver: Government intiatives to drive the demand for oncology information systems

Governments from all over the world are in the process of planning reforms and introducing new regulations that would help in the enterprise-wide and nation-wide adoption of information technologies, including oncology information systems, which aid in the transformation of healthcare systems. For example, in the US, the Health Information Technology for Economic and Clinical Health (HITECH) Act—enacted under the American Recovery and Reinvestment Act (ARRA)—allocated funding for incentivizing hospitals and physicians who demonstrate the meaningful use of EHRs. The availability of advanced Healthcare It solution  for cancer care is generating significant interest among end users owing to the better treatment outcomes promised by them.

Listed below are intiatives in recent years:

  • The NHS launched the Five Year Forward View in the UK to make all patient records “largely paperless” by 2020.
  • The National Electronic Health Record (NEHR) project was launched in Singapore to enable the vision of “One Patient, One Health Record,” with a budget of USD 127.83 million (SGD 176 million).

Restraint: High cost of oncology information systems

The cost of oncology information systems for different medical devices is considerably high. Affordability is a major challenge for healthcare organizations, especially in emerging economies, where it is typically very difficult to receive budgetary approvals for IT solutions over medical equipment. Smaller healthcare organizations struggle to implement Internet connectivity to medical devices, mainly due to difficulties in implementing multiple networks with health setups, the lack of wireless connectivity options, and a need to install security layers to avoid data breaches. . In addition, the infrastructural costs for implementing an oncology information system and associating it with different devices with distinct interfaces form a major obstacle to market growth in emerging regions. The implementation and subscription/licensing fees for integration solutions are a major financial burden and add to the budgetary woes faced by many hospitals

Opportunity: Marketing, promotion and branding initiatives undertaken by major product manufacturers

Major product manufacturers are undertaking strategic initiatives to increase their brand visibility and product awareness among key end users (such as medical professionals, patients, and oncologist) across major healthcare markets worldwide. Company operating in oncology information systems market are opting for hybrid distribution strategy as per which distribution takes place both by distribution channel and through partnership with global OIS vendors. Oncology information systems company has also adopted consignment model, according to which company places the tretament planning systems along with tretament delivery systems its customers and sales are made according to the implementation of medical devices. Such initiatives undertaken by major product manufacturers are expected to increase their brand awareness among target end-users as well as sensitize them about their role in preventive cancer care.

Challenge: Interoperability Issues

Many healthcare organizations have invested in a variety of oncology information system applications, such as patient information systems, treatment planning systems, treatment management systems and imaging systems, database management systems, and clinical information systems. Integration of these different oncology information systems, however, poses some obstacles—such as data privacy issues. Other issues include lack of data standardization (which leads to healthcare interoperability) and data inconsistency. The successful integration of oncology information systems with other systems is a focus of IT infrastructure development projects in healthcare organizations offering cancer diagnosis and treatment. This is considered a major challenge for the growth of the oncology information systems market during the study period

By product, the software products segment dominated the global oncology information systems market

Based on the product, the oncology information systems market is segmented into software, and professional services. Software products include patient information systems, treatment planning systems, and treatment management systems & medical image analysis systems.  The patient information systems segment dominated the oncology information systems market in 2019. Rising incidences of cancer, new product launches, coupled with the rising adoption of web- and cloud-based models, is expected to  fuels the growth of this segment during the forecast period.

By application, the radiation oncology products segment dominated the global oncology information systems market

Based on the application, the oncology information systems market is segmented into radiation oncology, medical oncology and surgical oncology. The radiation oncology segment accounted for a larger share of  in the market in 2019. The increasing installation base for radiotherapy devices, growing number of  radiosurgery procedures related to fractures, rapid growth in the cancer affected population across the globe, and the development of advanced radiology information systems and radiation treatment planning systems are factors expected to drive the growth of this market segment in the coming years.

By end user, the hospital segment accounted for the largest share of the oncology information systems market in 2019

Based on application, the oncology information systems market has been segmented into the hospitals & diagnostic imaging centers, ablation & cancer care centers, government institutions, and research facilities. Among these, the hospitals & diagnostic imaging centers segment accounted for the largest share of the market in 2019. The large share of this segment is attributed to the large target patient population base (especially in emerging countries) preferring hospitals, the growing procedural volume in hospital settings, rising emphasis on effective and early disease diagnosis in hospital, and the high budget of hospitals for introducing various technologically advanced oncology information systems products.

Oncology Information System Market  by Region

North America is expected to command the largest share of the oncology information systems market in 2019

The report covers the oncology information systems market across five major geographies, namely, Europe, North America, Asia Pacific, Latin America, and MEA. North America commanded the largest share of the oncology information systems market in 2019. The increasing R&D to develop patient centeric oncology information systems, rising prevalence of cancer, technological advancements in oncology information systems products and procedures are the key factors supporting market growth in North America. Moreover, most of the prominent companies in the global market are headquartered in the region or have a strong presence in this market, such as Varian Medical Systems, Inc (US), Accuray Incorporated (US), McKesson Corporation (US), and GE Healthcare (US) Others have focused on expansion to increase their reach and capabilities. This is another key factor attributed to the prominent growth of the market.

Key Market Players

The major players in the oncology information systems market are Koninklijke Philips N.V. (Netherlands), Varian Medical Systems, Inc (US), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US),  IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), AmerisourceBergen Corporation (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), and RaySearch Laboratories AB (Sweden), among others.

Varian Medical Systems, Inc (US) has a wide range of product offerings in the oncology information systems market, including radiotherapy treatment planning systems, radiation dose management solutions, clinical information management systems, medical image analysis systems, brachytherapy treatment planning solutions, oncology analytics, oncology electronic medical record, chemotherapy information systems products. The company sustains its key position in the global oncology information systems market owing to its multiple product launches. Varian Medical Systems, Inc (US  has a strong product portfolio, supporting around oncology procedures worldwide.The company is focused on innovations and improving the quality of its products with increasing investment in its R&D department. Varian Medical Systems, Inc global footprint allows it to cater to a customer base across North America, Europe, Middle East & Africa , and Asia Pacific.

Scope of the report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD Billion)

Segments covered

Product, Application, End User, and Region

Geographies covered

Europe, North America, the Asia Pacific, Latin America, and Middle East and Africa

Companies covered

Koninklijke Philips N.V. (Netherlands), Varian Medical Systems, Inc (US), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US),  IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), AmerisourceBergen Corporation (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), and RaySearch Laboratories AB (Sweden)

This report has segmented the global oncology information systems market based on product,  application, end user, and region.

Global Oncology information systems Market, by Product

  • Software
    • Patient Information Systems
      • Radiology Information systems
      • Oncology Electronic Medical Record (EHR)
      • Laboratory Information Systems
      • Chemotherapy Information System
    • Treatment Planning Systems
      • Clinical Decision Support Systems
      • Radiotherapy Treatment Planning Systems
      • Brachytherapy Treatment Planning Systems
    • Treatment Management Systems & Medical Image Analysis Systems
      • Population Health Management
      • Clinical Integration Solutions
      • Picture archiving and communication System (PACS) & VNA
      • Advanced Visulaization & Image Analysis Solutions
      • Radiation Dose Management Solutions
  • Professional Services
    • Consulting/Optimization Services
    • Implementation Services
    • Post-Sale and Maintenance Services

Global Oncology information systems Market, by Application

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Global Oncology information systems Market, by End User

  • Hospitals & Diagnostic Imaging Centers
  • Ablation  Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

Global Oncology information systems Market, by Region

    • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa

Recent Developments

  • In December 2020, Koninklijke Philips N.V. (Netherlands) introduced the advanced Philips IntelliSite Pathology Solution to enable precision diagnosis for oncology
  • In September 2020, Varian Medical Systems, Inc. (US) received FDa approval for the Eclipse v16.1 treatment planning software for proton therapy.
  • In September 2020, Siemens Healthineers entered into a definitive agreement to acquire Varian Medical Systems. This acquisition will strengthen the company’s existing portfolio of oncology information systems

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Indicative list of secondary sources
           2.1.2 PRIMARY DATA
           FIGURE 2 BREAKDOWN OF PRIMARIES: ONCOLOGY INFORMATION SYSTEMS MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
           FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
           2.2.2 END USER-BASED MARKET ESTIMATION
           FIGURE 4 MARKET SIZE ESTIMATION: ONCOLOGY INFORMATION SYSTEMS MARKET
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION
           FIGURE 5 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 44)
           FIGURE 6 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
           FIGURE 8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
           FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE ONCOLOGY INFORMATION SYSTEMS MARKET

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 ONCOLOGY INFORMATION SYSTEMS MARKET OVERVIEW
           FIGURE 10 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
    4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
           FIGURE 11 SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
    4.3 APAC: ONCOLOGY INFORMATION SYSTEMS MARKET SHARE, BY COUNTRY AND APPLICATION (2019)
           FIGURE 12 RADIATION ONCOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC ONCOLOGY INFORMATION SYSTEMS MARKET IN 2019
    4.4 ONCOLOGY INFORMATION SYSTEMS MARKET SHARE, BY END USER, 2020 VS. 2025
           FIGURE 13 HOSPITALS & DIAGNOSTIC IMAGING CENTERS ARE THE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS
    4.5 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 14 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 15 MARKET DYNAMICS: DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Cost-benefits of OIS vis-ΰ-vis rising healthcare expenditure
           TABLE 1 HEALTHCARE EXPENDITURE PER CAPITA (USD) & % OF GDP (2019)
                    5.2.1.2 Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality
                    5.2.1.3 Increasing incidence and prevalence of cancer
           TABLE 2 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015–2019
                    5.2.1.4 Favorable government mandates and support for oncology information systems
                    5.2.1.5 Potential benefits of and technological advancements in oncology information systems
           5.2.2 RESTRAINTS
                    5.2.2.1 Interoperability issues
                    5.2.2.2 High cost of oncology information systems
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare IT Industry
                    5.2.3.2 Integration of EMR with treatment planning systems
           5.2.4 CHALLENGES
                    5.2.4.1 Integration between various oncology information systems within the healthcare industry
    5.3 TECHNOLOGY ANALYSIS: HEALTHCARE IT SOLUTIONS
           FIGURE 16 HEALTHCARE IT SOLUTIONS: TECHNOLOGY EVOLUTION CURVE
    5.4 ECOSYSTEM LANDSCAPE: HEALTHCARE IT MARKET
    5.5 REGULATORY ANALYSIS
           5.5.1 NORTH AMERICA
                    5.5.1.1 US
           TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
           TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.5.1.2 Canada
           TABLE 5 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           FIGURE 17 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
           5.5.2 EUROPE
           FIGURE 18 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
           5.5.3 ASIA PACIFIC
                    5.5.3.1 Japan
           TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.5.3.2 China
           TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.5.3.3 India
    5.6 COVID-19 IMPACT

6 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE (Page No. - 73)
    6.1 INTRODUCTION
           TABLE 8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
    6.2 SOFTWARE
           TABLE 9 SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 10 SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.1 PATIENT INFORMATION SYSTEMS
           TABLE 11 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 12 PATIENT INFORMATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.1.1 Oncology electronic medical records
                               6.2.1.1.1 The adoption of oncology electronic health records is growing significantly in emerging countries
           TABLE 13 ONCOLOGY ELECTRONIC MEDICAL RECORDS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.1.2 Laboratory information systems
                               6.2.1.2.1 The need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth
           TABLE 14 LABORATORY INFORMATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.1.3 RADIOLOGY INFORMATION SYSTEMS
                               6.2.1.3.1 The integration of RIS with HIS and PACS has attracted attention from stakeholders
           TABLE 15 RADIOLOGY INFORMATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.1.4 Chemotherapy information systems
                               6.2.1.4.1 Chemotherapy is increasingly being adopted as a primary mode of treatment for various cancer types
           TABLE 16 CHEMOTHERAPY INFORMATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.2 TREATMENT PLANNING SYSTEMS
           TABLE 17 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 18 TREATMENT PLANNING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.2.1 Radiotherapy treatment planning systems
                               6.2.2.1.1 Radiotherapy treatment planning systems to witness increased adoption for the treatment of deep-seated tumors
           TABLE 19 RADIOTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.2.2 Clinical decision support systems
                               6.2.2.2.1 Need to minimize errors and ensure regulatory compliance to drive the adoption of CDSS
           TABLE 20 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.2.3 Brachytherapy treatment planning systems
                               6.2.2.3.1 Better patient care with pulsed-dose rate brachytherapy to drive the demand for brachytherapy treatment planning systems
           TABLE 21 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.3 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS
           TABLE 22 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 23 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.3.1 Population health management solutions
                               6.2.3.1.1 PHM solutions aggregate and provide a wide range of cancer data for providers
           TABLE 24 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.3.2 Clinical integration solutions
                               6.2.3.2.1 Increasing number of cancer patient admissions in inpatient facilities is a key driver
           TABLE 25 CLINICAL INTEGRATION SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.3.3 Picture archiving and communication systems & vendor-neutral archive solutions
                               6.2.3.3.1 Rising demand for PACS and growing generation of image data will ensure sustained demand for solutions
           TABLE 26 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.3.4 Advanced visualization and image analysis solutions
                               6.2.3.4.1 Increasing demand for imaging modalities in various indications of oncology to drive the segment growth
           TABLE 27 ADVANCED VISUALIZATION AND MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    6.2.3.5 Radiation dose management solutions
                               6.2.3.5.1 Use of these solutions allows for the optimization of radiation dose administration and management
           TABLE 28 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY REGION, 2018–2025 (USD MILLION)
    6.3 PROFESSIONAL SERVICES
           TABLE 29 PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 30 PROFESSIONAL SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.1 IMPLEMENTATION SERVICES
                    6.3.1.1 Healthcare organizations are increasingly outsourcing implementation services
           TABLE 31 IMPLEMENTATION SERVICES OFFERED BY KEY MARKET PLAYERS
           TABLE 32 IMPLEMENTATION SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.2 POST-SALES & MAINTENANCE SERVICES
                    6.3.2.1 Rising trend of outsourcing driving the market for support & maintenance services
           TABLE 33 SUPPORT & MAINTENANCE SERVICES OFFERED BY KEY MARKET PLAYERS
           TABLE 34 POST-SALES & MAINTENANCE SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.3 CONSULTING & OPTIMIZATION SERVICES
                    6.3.3.1 Consulting services deliver optimum guidance to healthcare providers for implementing oncology information solutions
           TABLE 35 CONSULTING SERVICES OFFERED BY KEY MARKET PLAYERS
           TABLE 36 CONSULTING & OPTIMIZATION SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)

7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION (Page No. - 97)
    7.1 INTRODUCTION
           TABLE 37 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    7.2 RADIATION ONCOLOGY
           7.2.1 GROWING NUMBER OF RADIATION-TREATED CANCER SURVIVORS ENHANCING THE GROWTH OF ONCOLOGY INFORMATION SYSTEMS
           TABLE 38 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND)
           TABLE 39 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY, BY REGION, 2018–2025 (USD MILLION)
    7.3 MEDICAL ONCOLOGY
           7.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
           TABLE 40 ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY, BY REGION, 2018–2025 (USD MILLION)
    7.4 SURGICAL ONCOLOGY
           7.4.1 NEED FOR STRUCTURED HEALTHCARE INFORMATION SYSTEMS TO BOOST MARKET GROWTH
           TABLE 41 ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY, BY REGION, 2018–2025 (USD MILLION)

8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER (Page No. - 103)
    8.1 INTRODUCTION
           TABLE 42 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2018–2025 (USD MILLION)
    8.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS
           8.2.1 HOSPITALS AND DIAGNOSTIC IMAGING CENTERS ARE THE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS
           TABLE 43 ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018–2025 (USD MILLION)
    8.3 ABLATION & CANCER CARE CENTERS
           8.3.1 INITIATION OF CANCER CARE PROGRAMS AND SUPPORTING REIMBURSEMENT PLANS TO BOOST THE GROWTH OF THIS SEGMENT
           TABLE 44 ONCOLOGY INFORMATION SYSTEMS MARKET FOR ABLATION & CANCER CARE CENTERS, BY REGION, 2018–2025 (USD MILLION)
    8.4 GOVERNMENT INSTITUTIONS
           8.4.1 RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH
           TABLE 45 ONCOLOGY INFORMATION SYSTEMS MARKET FOR GOVERNMENT INSTITUTIONS, BY REGION, 2018–2025 (USD MILLION)
    8.5 RESEARCH FACILITIES
           8.5.1 GROWING NUMBER OF CANCER RESEARCH STUDIES TO DRIVE MARKET GROWTH
           TABLE 46 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH FACILITIES, BY REGION, 2018–2025 (USD MILLION)

9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION (Page No. - 109)
    9.1 INTRODUCTION
           TABLE 47 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 19 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
           TABLE 48 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 49 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 50 NORTH AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 51 NORTH AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 52 NORTH AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 53 NORTH AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 54 NORTH AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 55 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 56 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,BY END USER, 2018–2025 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Rising adoption of oncology information systems in hospitals to drive market growth in the US
           TABLE 57 US: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 58 US: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 59 US: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 60 US: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 61 US: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 62 US: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising lung cancer incidence to increase the demand for OIS in Canada
           TABLE 63 CANADA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 64 CANADA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 65 CANADA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 66 CANADA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 67 CANADA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 68 CANADA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
    9.3 EUROPE
           TABLE 69 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 70 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 71 EUROPE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 72 EUROPE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 73 EUROPE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 74 EUROPE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 75 EUROPE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 76 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 77 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 High adoption of EHR systems among healthcare practitioners to drive market growth in Germany
           TABLE 78 GERMANY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 79 GERMANY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 80 GERMANY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 81 GERMANY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 82 GERMANY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 83 GERMANY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 The UK is rapidly transforming its organizations into paperless environments through EHRs
           TABLE 84 UK: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 85 UK: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 86 UK: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 87 UK: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 88 UK: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 89 UK: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Growing reforms in digital health will support market growth
           TABLE 90 FRANCE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 91 FRANCE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 92 FRANCE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 93 FRANCE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 94 FRANCE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 95 FRANCE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increasing government initiatives and reforms to drive market growth
           TABLE 96 ITALY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 97 ITALY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 98 ITALY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 99 ITALY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 100 ITALY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 101 ITALY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing prevalence of cancer to support the growth of the oncology information systems market in Spain
           TABLE 102 SPAIN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 103 SPAIN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,2018–2025 (USD MILLION)
           TABLE 104 SPAIN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 105 SPAIN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 106 SPAIN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 107 SPAIN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.3.6 REST OF EUROPE
           TABLE 108 ROE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 109 ROE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 110 ROE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 111 ROE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 112 ROE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 113 ROE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 20 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT
           TABLE 114 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 115 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 116 ASIA PACIFIC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 117 ASIA PACIFIC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 118 ASIA PACIFIC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 119 ASIA PACIFIC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 120 ASIA PACIFIC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 121 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 122 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Japan dominated the Asia Pacific oncology information systems market in 2019
           TABLE 123 JAPAN: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 124 JAPAN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 125 JAPAN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 126 JAPAN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 127 JAPAN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 128 JAPAN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Strong government support in China is driving the healthcare IT market
           TABLE 129 CHINA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 130 CHINA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 131 CHINA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 132 CHINA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 133 CHINA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 134 CHINA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Rising medical tourism to drive market growth in India
           TABLE 135 INDIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 136 INDIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 137 INDIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 138 INDIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,2018–2025 (USD MILLION)
           TABLE 139 INDIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 140 INDIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Supportive government initiatives and technological advancements to drive market growth
           TABLE 141 AUSTRALIA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 142 AUSTRALIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 143 AUSTRALIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,2018–2025 (USD MILLION)
           TABLE 144 AUSTRALIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 145 AUSTRALIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 146 AUSTRALIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.4.5 SOUTH KOREA
                    9.4.5.1 Supportive government initiatives expected to positively impact market growth
           TABLE 147 SOUTH KOREA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 148 SOUTH KOREA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 149 SOUTH KOREA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 150 SOUTH KOREA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 151 SOUTH KOREA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 152 SOUTH KOREA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.4.6 REST OF ASIA PACIFIC
           TABLE 153 ROAPAC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 154 ROAPAC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 155 ROAPAC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 156 ROAPAC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 157 ROAPAC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 158 ROAPAC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,BY TYPE, 2018–2025 (USD MILLION)
    9.5 LATIN AMERICA
           TABLE 159 LATAM: ONCOLOGY INFORMATION SYSTEMS, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 160 LATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 161 LATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 162 LATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 163 LATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 164 LATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 165 LATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 166 LATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 167 LATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2018–2025 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Modernization of healthcare facilities to drive market growth
           TABLE 168 BRAZIL: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 169 BRAZIL: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 170 BRAZIL: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,2018–2025 (USD MILLION)
           TABLE 171 BRAZIL: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 172 BRAZIL: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 173 BRAZIL: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Favorable government initiatives and growing medical tourism to drive market growth
           TABLE 174 MEXICO: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 175 MEXICO: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 176 MEXICO: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 177 MEXICO: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 178 MEXICO: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 179 MEXICO: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
           TABLE 180 ROLATAM: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 181 ROLATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 182 ROLATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 183 ROLATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 184 ROLATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 185 ROLATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,BY TYPE, 2018–2025 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH IN THE REGION
           TABLE 186 MEA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
           TABLE 187 MEA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,2018–2025 (USD MILLION)
           TABLE 188 MEA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 189 MEA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 190 MEA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 191 MEA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 192 MEA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 193 MEA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 188)
     10.1 OVERVIEW
           FIGURE 21 KEY DEVELOPMENTS IN THE ONCOLOGY INFORMATION SYSTEMS MARKET (2017–2020)
     10.2 GLOBAL MARKET SHARE ANALYSIS (2019)
           FIGURE 22 VARIAN MEDICAL SYSTEMS, INC. HELD THE LEADING POSITION IN THE ONCOLOGY INFORMATION SYSTEMS MARKET IN 2019
     10.3 COMPETITIVE SCENARIO (2017–2020)
             10.3.1 KEY PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND PRODUCT APPROVALS
             10.3.2 KEY EXPANSIONS
             10.3.3 KEY MERGERS AND ACQUISITIONS
             10.3.4 KEY AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
     10.4 COMPETITIVE LEADERSHIP MAPPING
     10.5 VENDOR INCLUSION CRITERIA
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
           FIGURE 23 ONCOLOGY INFORMATION SYSTEMS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
     10.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2019)
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
           FIGURE 24 ONCOLOGY INFORMATION SYSTEMS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)

11 COMPANY PROFILES (Page No. - 197)
(Business Overview, Products Offered, Recent Developments, MnM View)* 
     11.1 MCKESSON CORPORATION
           FIGURE 25 MCKESSON CORPORATION: COMPANY SNAPSHOT (2019)
     11.2 VARIAN MEDICAL SYSTEMS, INC.
           FIGURE 26 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2019)
     11.3 ELEKTA AB
           FIGURE 27 ELEKTA AB: COMPANY SNAPSHOT (2019)
     11.4 SIEMENS HEALTHINEERS
           FIGURE 28 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)
     11.5 PHILIPS HEALTHCARE
           FIGURE 29 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2019)
     11.6 GE HEALTHCARE
           FIGURE 30 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2019)
     11.7 CERNER CORPORATION
           FIGURE 31 CERNER CORPORATION: COMPANY SNAPSHOT (2019)
     11.8 IBM
           FIGURE 32 IBM: COMPANY SNAPSHOT (2019)
     11.9 ACCURAY INCORPORATED
           FIGURE 33 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2019)
     11.10 EPIC SYSTEMS CORPORATION
     11.11 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
           FIGURE 34 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2019)
     11.12 F. HOFFMANN-LA ROCHE AG
           FIGURE 35 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)
     11.13 RAYSEARCH LABORATORIES AB
           FIGURE 36 RAYSEARCH LABORATORIES AB: COMPANY SNAPSHOT (2019)
     11.14 CUREMD HEALTHCARE
     11.15 BOGARDUS MEDICAL SYSTEMS, INC.
     11.16 OTHER COMPANIES
             11.16.1 OPTUM
             11.16.2 MICA INFORMATION SYSTEMS, INC.
             11.16.3 ADVANCED DATA SYSTEMS
             11.16.4 ENDOSOFT, LLC
             11.16.5 AMERISOURCEBERGEN CORPORATION
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies. 

12 APPENDIX (Page No. - 256)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the oncology information systems market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Primary research was conducted after acquiring extensive knowledge about the global oncology information systems market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as hospitals, ambulatory surgery centers, outpatient facilities, clinics, cancer care centers, ablation care centers research universities, academic institutions, and government institutions, among others) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 30% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Oncology Information System Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

A detailed market estimation approach was followed to estimate and validate the size of the global oncology information systems market and other dependent submarkets.

  • The key players in the global oncology information systems market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights on the global oncology information systems market.
  • All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources.
  •  All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Oncology Information System Market  Size, and Estimation

Data Triangulation:

After deriving the overall oncology information systems market value data from the market size estimation process, the total market value data was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various qualitative and quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Report Objectives:

  • To define, describe, and forecast the oncology information systems market on the basis of product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth potential of the global oncology information systems market (drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global oncology information systems market
  • To analyze key growth opportunities in the global oncology information systems market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa
  • To profile the key players in the global oncology information systems market and comprehensively analyze their market shares and core competencies
  • To track and analyze the competitive developments undertaken in the global oncology information systems market, such as product launches; agreements, partnerships, and collaborations; expansions; and mergers & acquisitions

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global oncology information systems market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe oncology information systems market into Belgium, Austria, the Czech Republic, Denmark, Greece, Poland, and Russia, among other
  • Further breakdown of the Rest of Asia Pacific oncology information systems market into wan, New Zealand, Vietnam, the Philippines, Singapore, Malaysia, Thailand, and Indonesia among other
  • Further breakdown of the Latin American oncology information systems market into Argentina, Chile, Peru, and Colombia, among other
COVID-19

Get in-depth analysis of the COVID-19 impact on the Oncology Information System Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Oncology Information System Market

Request For Special Pricing
Report Code
HIT 3267
Published ON
Feb, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Oncology Information System Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home